Blood clues: could two proteins reveal how diabetes harms kidneys?
NCT ID NCT07749664
First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This study looks at whether two blood markers—DEL-1, an anti-inflammatory protein, and thromboxane A2, a sign of platelet activity—are linked to diabetic nephropathy, a common kidney complication of diabetes. Researchers will measure these markers in 80 adults, including patients with diabetic nephropathy and healthy controls, to see if they relate to disease severity. The goal is to explore whether these markers could serve as indicators for diagnosis or tracking the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If certain blood markers are linked to diabetic kidney disease severity, they could become tools for earlier diagnosis or monitoring.
- What could go wrong
- This is a small observational study, so it can only show associations, not cause and effect. The findings may not lead to practical tests or treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEPHROPATHY, DIABETIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.